Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Rosuvastatin Peri-PCI in Chinese NSTE-ACS Patients
NCT02284503Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in non-ST elevation acute coronary syndrome (NSTE-ACS), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT02284503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284503.